Telos Capital Management, Inc. Organon & Co. Transaction History

Telos Capital Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	SELL	$23.31 - $28.61 $536 - $658	-23 Reduced 0.19%	12,347 $0
Q3 2022 Oct 31, 2022	SELL	$23.4 - $34.25 $27,939 - $40,894	-1,194 Reduced 8.8%	12,370 $289,000
Q2 2022 Aug 08, 2022	SELL	$31.66 - $38.9 $6,015 - $7,391	-190 Reduced 1.38%	13,564 $458,000
Q1 2022 May 02, 2022	SELL	$30.45 - $39.36 $9,013 - $11,650	-296 Reduced 2.11%	13,754 $480,000
Q4 2021 Jan 21, 2022	SELL	$28.67 - $37.13 $9,375 - $12,141	-327 Reduced 2.27%	14,050 $428,000
Q3 2021 Oct 19, 2021	SELL	$28.63 - $35.64 $79,133 - $98,508	-2,764 Reduced 16.13%	14,377 $471,000
Q2 2021 Jul 15, 2021	BUY	$28.45 - $38.0 $487,661 - $651,358	17,141 New	17,141 $519,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Telos Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Telos Capital Management, Inc. with notifications on news.